BRAEGEN PHARMACEUTICAL
Braegen Pharmaceutical Company, is based in China. The company is developing drugs for neurodegenerative diseases including Alzheimer’s disease. The Emory intellectual property licensed to the company relates to a series of small molecule precursors to7, 8-dihydroxyflavone (7, 8 DHF), a potent tyrosine receptor kinase B (TrkB) agonist, for the treatment of various neurological diseases.
BRAEGEN PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Atlanta, Georgia, United States
Country:
United States
Status:
Active
Similar Organizations
Neuromagen Pharma
Neuromagen Pharma develops drugs for neurodegenerative diseases including ALS.
Synaps Dx
Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.